lunes, 8 de febrero de 2010

Drug Safety Update

La agencia britanica ya ha publicado el numero correspondiente a febrero del boletin Drug Safety Update

En este numero

Drug safety advice
• Tacrolimus: new oral liquid (Modigraf); formulations not interchangeable without careful therapeutic monitoring.

Yellow Card Scheme update
• Problem with postal delivery of Yellow Cards.

Swine flu portal update
• Suspected adverse reactions to flu antivirals and vaccines confirm recognised safety profile.

Hot topics
• Orlistat safety update.
• Nicotine replacement therapy and harm reduction.

Stop press
• Sibutramine: suspension of EU licenses recommended as evidence indicates risks outweigh benefits.
• Off-label intraocular use of recombinant tissue plasminogen activator: risk of intraocular lens opacification.
• Please report suspected adverse reactions associated with intra-articular use of local anaesthetics.

Other information from the MHRA
• Patient Information Leaflet of the month: amoxicillin.

El enlace en
http://tinyurl.com/y9edr8h